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Abstract Since decades it has been known that non-
protein-coding RNAs have important cellular functions.
Deep sequencing recently facilitated the discovery of
thousands of novel transcripts, now classified as long non-
coding RNAs (lncRNAs), in many vertebrate and
invertebrate species. LncRNAs are involved in a wide range
of cellular mechanisms, from almost all aspects of gene
expression to protein translation and stability. Recent
findings implicate lncRNAs as key players of cellular dif-
ferentiation, cell lineage choice, organogenesis and tissue
homeostasis. Moreover, lncRNAs are involved in patho-
logical conditions such as cancer and cardiovascular
disease, and therefore provide novel biomarkers and phar-
maceutical targets. Here we discuss examples illustrating
the versatility of lncRNAs in gene control, development and
differentiation, as well as in human disease.
Keywords LncRNA  Differentiation 
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Introduction
It has long been known that several classes of non-protein-
coding RNA molecules exert important cellular functions.
For instance, ribosomal RNAs (rRNAs) are essential ele-
ments of the translation machinery and small nuclear
RNAs (snRNAs) are required for splicing of nascent RNA
transcripts. Also, various classes of small (around 20–30
nucleotides) noncoding RNAs such as micro (mi)RNAs,
small inhibitory (si)RNAs or PIWI interacting (pi)RNAs
are well known as gene silencers. With the recent advent of
massive parallel sequencing techniques, however, it has
been observed that a tremendously high portion, approxi-
mately 70 %, of the genome is transcribed in various
contexts and cell types [1, 2]. A large proportion of these
newly detected RNA transcripts are structurally indistin-
guishable from protein-coding and processed messenger
RNAs (mRNAs). They tend to be expressed at a very low
level and have little to no protein-coding potential. This
subclass of noncoding transcripts of variable length and
function is collectively referred to as long noncoding
RNAs (lncRNAs).
A plethora of biological tissues, organs, pathological
samples and cultured cells have been analyzed for non-
coding RNA expression, and it is clear that these molecules
are omnipresent. Apparently, defining noncoding RNA
function has proven more challenging than detecting them,
as the number of reports showing comprehensive func-
tional data is far smaller than those describing their
identification in various contexts. The flexibility of RNA
transcripts and their ability to fold into complex 3D-con-
formations enables them to form specific interactions with
proteins. They can interact with RNA or DNA molecules
via base pairing, even with double-stranded DNA, and
form networks with DNA, protein complexes and RNA
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molecules, illustrating their large potential as an important
player with many biological functions. In this review, we
will discuss mechanisms of lncRNA functions with a focus
on their role in development and disease (Table 1).
Molecular and genetic structure of LncRNAs
Like mRNAs, lncRNAs are transcribed by Polymerase II,
mostly 50-capped, polyadenylated and spliced, though on
average they contain a lower number of exons than
mRNAs and their expression level assessed across different
tissues is lower [3, 4]. There are various algorithms cal-
culating the coding probability based on the length of a
potential open reading frame (ORF), the similarity of such
an ORF to known protein-coding genes, frequency of in-
frame nucleotide hexamers or other empirical sequence
features [5]. In general, RNA transcripts containing short
(\100 nt) non-conserved ORFs, which have no homology
to known peptide sequences and do not match to peptides
identified in mass spectrometry screens are considered
noncoding [6]. Interestingly, the majority of lncRNAs are
associated with ribosomes [7, 8], though they do not show
the characteristic release of ribosomes [9] or the typical
3-nucleotide phasing corresponding to codons of an ORF
[10, 11]. However, in rare instances, functional
oligopeptides have been found to be translated from puta-
tive lncRNAs [12–14].
Deep-sequencing experiments revealed many examples
of genes producing both protein-coding and noncoding
transcripts by alternative splicing. However, so far, only
very few reports demonstrate a functional role for both the
noncoding RNA(s) and the protein(s) encoded by tran-
scripts derived from the same gene [15, 16]. It is tempting
to speculate that such dual usage of transcripts is more
frequent than anticipated.
RNA molecules have the potential to form highly
structured macromolecules by folding into double-stranded
stems, single-stranded loops and bulges, which again can
fold further into three-dimensional structures, allowing for
the potential formation of complex shapes. So far, the
structure of only a few RNAs has been experimentally
determined using a combination of chemical assays, and by
determining the accessibility of base-paired or single-
stranded RNA by various RNases [17, 18]. However, these
methods still have the limitation that they can only reveal
the secondary, but not the tertiary (3D) structure. In addi-
tion, computational predictions are only beginning to
provide reliable results, but program learning from exper-
imental data might improve the predictions and more






















Fig. 1 Classification of lncRNAs according to their position relative
to neighboring gene(s). a Divergently transcribed lncRNA originating
from the same promoter region as the adjacent (usually protein
coding) gene, but from the opposite strand; b convergently tran-
scribed genes encoded on opposite strands and facing each other;
c intergenic (or intervening) lncRNA (or lincRNA) located distant
from other genes (usually[10 kb); d examples for various cases of
lncRNAs overlapping with other genes on the same or the opposite
strand; e enhancer RNAs expressed as uni- or bidirectional tran-
scripts; f LncRNA transcribed from an intron of another gene;
g lncRNA hosting a miRNA. Noncoding genes are shown in green,
protein-coding genes in orange
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accelerated by recently developed techniques combined
with high-throughput sequencing, such as SHAPE-MaP
and icSHAPE [19, 20].
The similarity between mRNA-encoding and lncRNA
genes is furthermore reflected by the chromatin signatures at
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Fig. 2 Schematic representation of cellular mechanisms involving
lncRNAs. a LncRNA transcripts evicting proteins from chromatin;
here, pancRNAs prevent DNMT from methylating DNA in their
promoter region, thereby ensuring mRNA transcription. b LncRNAs
recruiting the Mediator complex to an enhancer region, stabilizing
loop formation and transcription of the associated gene. c LncRNAs
transcribed from an enhancer region interfering with enhancer-
promoter contact, thereby inhibiting transcription of the protein-
coding gene. d LncRNA recruiting proteins, such as chromatin-
modifying complexes to specific target sites in the genome, e.g. via
DNA-RNA triplex formation. e LncRNA acting as scaffold linking
different proteins required for concerted action. f LncRNA binding
and sequestering proteins to prevent or attenuate their action, e.g.
binding to mRNAs (left); circRNA sequestering miRNAs to prevent
their binding to mRNAs (right). g Example of a lncRNA changing the
splicing pattern by binding to a primary RNA transcript. h LncRNA
stabilizing a mRNA by recruiting proteins such as STAU1, thereby
preventing degradation
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ERVMER34 Nucleus Histone modification Epidermal differentiation [139, 140]





RSL1D1 Nucleus Histone modification Breast cancer [82]
BRAFP1 (Braf-rs1) Pseudo gene ZDHHC15 Cytoplasm Post transcriptional DLBCL [158]
Braveheart (Bvht) LincRNA IL17b Nucleus Histone modification Cardiac differentiation [45]
CDR1 CircRNA CDR1 Cytoplasm Post transcriptional Neuronal tissue [26, 27]
DACOR1
(TCONS_00023265)
LincRNA SMAD3 Nucleus DNA methylation Colon cancer [74]
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Foxf1 Nucleus Histone modification Development [47, 123]
FIRRE LincRNA RNA5SP514 Nucleus 3D genome
organization
3D genome structure [103]
Gtl2 (MEG3) LincRNA RTL1 Nucleus Histone modification,
DNA methylation
Imprinting [55, 122, 177]












n.d. n.d. Myeloid cancer cell lines [178]
Hotdog Enhancer
RNA
HoxD Nucleus Enhancer Development [179]
HOTTIP Divergent
lncRNA
HOXA13 Nucleus Histone modification Limb development [62]
Jpx LincRNA Xist Nucleus Transcription factor X-chromosome
inactivation
[83, 84]
Lethe Pseudo gene Gmeb1 Nucleus Transcription factor Inflammation [79]
Linc-HOXA1
(Linc1547, HAUNT)
LincRNA HOXA1 Nucleus Enhancer, histone
modification
Development [99, 123]
Linc-P21 LincRNA p21 Nucleus Transcription factor Cancer, CVD [123, 163, 165, 166]
Lnc-DC LincRNA HEATR6 Cytoplasm Transcription factor Dendritic cell
differentiation
[81]
LncMyoD LincRNA Munc, MyoD1 Both Post transcriptional Muscle differentiation [180]







Nucleus Transcription factor Acute leukemia [151]
MALAT1 (NEAT2) LincRNA SCVL1 Nucleus Post transcriptional Metastasis [109, 110, 149]































CASC15 Nucleus Histone modification Neuronal differentiation,
different tumors
[148, 150]




NeST (Tmevpg1) LincRNA IFNg Nucleus Histone modification Infections [63]
NKILA Overlapping PMEPA1 Cytoplasm Transcription factor Breast cancer [153, 154]
NORAD (LINC00657) LincRNA CNBD2 Cytoplasm Post transcriptional Genomic stability [111]
PACER Divergent
lncRNA
COX2/PTGS2 Nucleus Transcription factor Infection [80]
pancIL17d Divergent
lncRNA





MAT2A Both Histone modification Increased in plasma from
patients post-radiation
[54]
PCGEM1 LincRNA TMEF2 Nucleus Transcription factor,
histone
modification
Prostate cancer [101, 144, 181]
Pint Divergent
lncRNA





Pou3f2 Nucleus Post transcriptional Neuronal differentiation [105]
PRNCR1 LincRNA CASC19 Nucleus Transcription factor,
histone
modification
Prostate cancer [101, 181]
RMST LincRNA NEDD1 Nucleus Transcription factor Neuronal differentiation [78, 129, 133]
RNCR4 Divergent
lncRNA
Mirc35HG Both Post transcriptional Retina development [136]





TCF21 Nucleus DNA methylation Different cancer types [65]
TINCR LincRNA SAFb2 Cytoplasm Post transcriptional Epidermal differentiation [141, 142]
Tsix LincRNA/
antisense










LincRNA Tcl1 Both Post transcriptional Pluripotency, Huntington [33, 106]
Twin of Hotdog Enhancer
RNA
HoxD Nucleus Enhancer Development [179]
UCA1 LincRNA OR10H1 Cytoplasm Post transcriptional Senesence [162]
Xist LincRNA/
antisense







[40, 71, 120, 121,
182, 183]
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transcriptional start site is, in most cases, marked by the
H3K4me3 histone modification and the transcribed region by
theH3K36me3mark, nomatter if the lncRNAoriginates from
its own promoter or froman enhancer. However, these histone
marks are less prominent than observed at mRNA coding
genes,whereasH3K4me1, a characteristicmark of enhancers,
tends to be more prominent at genomic regions encoding
lncRNAs [2, 21–23]. As expected for transcribed regions,
lncRNA promoters correspond with DNaseI hypersensitive
sites, which indicates accessible chromatin [24, 25].
So far, the most commonly used categorization of the
highly heterogeneous class of lncRNAs is their position
in the genome relative to protein-coding genes (Fig. 1).
LncRNAs can be intergenic (lincRNAs) or divergently
transcribed from the same promoter as a protein-coding
gene (pancRNAs). LincRNAs expressed from a promoter
(with high H3K4me3 to H3K4me1 ratio) are classified as
promoter-associated lncRNAs (plncRNAs). However,
lncRNAs can also be transcribed from enhancers and are
then termed eRNAs. They are mostly transcribed in both
directions, in contrast to enhancer-associated lncRNAs
(elncRNAs), which are unidirectionally transcribed from a
promoter with low H3K4me3 to H3K4me1 ratio [23].
Transcription of lncRNAs can also originate from within
introns, or overlap with other transcripts in sense or anti-
sense orientation [3]. Some lncRNAs are generated by
backsplicing from introns of mRNAs or other lncRNAs and
are thus circular (circRNAs) [26, 27].
Genome-wide sequencing of RNA species isolated from
cytosolic or nuclear fractions of cells has shown that the
majority of lncRNAs tend to be localized in the nucleus or are
associated with chromatin, while a considerable fraction
localizes to the cytoplasm [3, 28, 29]. The subcellular local-
ization is a good indication of the putative function of a
lncRNA, since in contrast to protein-coding mRNAs,
lncRNAs can already function while transcription is occur-
ring. In fact, many nuclear and, in particular, chromatin-
retained lncRNAs co-regulate transcription and/or chromatin
structure at or close to their site of transcription, i.e. in cis.
Conservation and evolutionary aspects of LncRNA
The genomic sequences of lncRNAs are, in general, less
conserved than exons, but more than introns of protein-
coding genes, pointing towards a rapid evolution with
moderate constraints [21, 30]. In contrast to the actual
sequence, splice sites of lncRNAs have been found to be
more stable during evolution [31, 32]. Despite poor RNA
sequence conservation, lncRNAs have frequently been
identified across species in syntenic genomic regions [33,
34]. It is therefore quite likely that evolutionary conser-
vation of lncRNAs is embodied by a conserved 3D
structure, although this is difficult to assess with current
methods. A further layer of conservation is functional
conservation between lncRNAs playing equivalent roles in
particular biological settings [35].
A different explanation for low conservation of
lncRNAs is the increasing number of such transcripts in
increasingly complex species. This finding, in combination
with the observed highly tissue-specific expression of many
lncRNAs, suggests that lncRNAs might be key molecules
promoting species-specific features and organ complexity
[36–38]. Thus, lncRNAs very likely have played important
roles in the evolution of complex organisms.
LncRNAs regulate gene and genome activity
The best-described function for lncRNAs in the nucleus is
their role in regulating gene and genome activity on various
levels (Fig. 2a–e). Many possible mechanisms by which
lncRNAs influence chromatin modifications and chromatin
structure, and thereby influence transcription or other chro-
matin-related functions by epigenetic mechanisms have
been investigated. In the following section we will address
different levels of gene and genome regulation separately.
Histone modifications regulated by LncRNAs
Prominent examples of histone-modifying complexes
interacting with lncRNAs are the two polycomb repressive
complexes, PRC1 and, in particular PRC2, which mediates
methylation of lysine 27 on histone 3 (H3K27me), a his-
tone mark associated with repressed or poised genetic loci.
The first report of an interaction of PRC2 with a noncoding
RNA came from studies on X-chromosome inactivation in
mammals, which involves X-inactive specific transcript
(Xist), a lncRNA that is highly expressed from the inactive
X-chromosomes in females (Xi) and recruits PRC2 to the
Xi to silence gene expression [39–41].
Another prominent example is Hotair, a conserved
lncRNA that is transcribed from within the HoxC gene
cluster. Hotair was shown to play a repressive role at the
HoxD locus by interacting with PRC2. In addition, Hotair
also interacts with the histone H3K4me1/2 demethylase
LSD1 (KDM1), which removes a histone mark of active
chromatin and thus reinforces the establishment of a repres-
sive chromatin environment on target loci [42] (Fig. 2d, e).
Targeted inactivation of Hotair in mice leads to de-repression
of imprinted genes and of HoxD genes, which lose H3K27-
methylation and gain H3K4-methylation marks, as expected
from loss of the enzymatic activity of PRC2 and LSD1 at
these loci. Furthermore, Hotair knockout mice show skeletal
homeotic transformation phenotypes, which are typical for
mutations affecting Polycomb mediated repression [43].
Interestingly, mice lacking most of the HoxC cluster
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including Hotair do not display these phenotypes, suggesting
a complex interplay of multiple genomic regions in regulating
HoxC cluster gene expression [44].
Braveheart (Bvht) is a lncRNA that is activated during
early cardiac differentiation and acts upstream of MESP1, a
basic Helix-loop-helix transcription factor involved in
early heart development. Bvht also exerts its function via
an interaction with PRC2 [45]. The lncRNA Fetal-lethal
developmental regulatory RNA (Fendrr; or Foxf1 adjacent
noncoding developmental regulatory RNA) is likewise
involved in cardiac development and heart function and
interacts with PRC2. Fendrr also interacts with WDR5,
which is well known for its presence in the MLL com-
plexes that mediate H3K4 methylation, a mark that is
thought to oppose H3K27me. Fendrr might play a role at
poised genes, or is involved in tuning the balance of active
and repressive marks at its target gene promoters, thus
adjusting the correct expression level of its targets [46, 47].
These examples are only a small selection and many more
lncRNAs seem to function in concert with the PRC2
complex; for more examples, see [48–52].
An intriguingmechanism as to how lncRNAsmight recruit
their protein interaction partners to specific genomic loci is
DNA-RNA triplex formation [53], which has been proposed
for several lncRNAs forming a complex with PRC2 [46, 54,
55] (Fig. 2d). In thismanner, lncRNAsmight direct chromatin
or transcriptional modulators to specific genomic sites. This
could explain, to some extent, the site-specific action of
chromatin-modifying complexes, which do not themselves
bind to DNA in a sequence specific manner [38, 56].
An example of a lncRNA interacting with the PRC1
complex is Focally amplified lncRNA on Chromosome 1
(FAL1). The interaction of FAL1 with BMI1, an essential
subunit of PRC1, regulates its protein stability [57]. The
knockdown ofFAL1 in an ovarian cancer cell line led to gene
expression changes, slower cell cycle progression and
induction of senescence, similar to the effects of the BMI1
knockdown. This latter phenotype could be partially rescued
by knockdown of the senescence-promoting factorCDKN1A
(p21). Additional ChIP data suggested that BMI1 binds to the
promoter of CDKN1A and, together with FAL1, suppresses
the expression of this target and of many other genes.
Whereas FAL1 acts in trans on PRC1, ANRIL, a lncRNA
transcribed from the INK4B-ARF-INK4A tumor suppressor
locus, acts in cis. The ANRIL transcript was discovered in a
family with inherited melanoma-neural system tumors and
assumed to play a role in tumorigenesis [58]. ANRIL recruits
CBX7 (a PRC1 component) via a POLII-dependent mech-
anism to its locus in order to repress the neighboring INK4B-
ARF-INK4A genes, antagonize cellular senescence and
indirectly promote cell cycle activity [58, 59].
The repressive H3K27-methylation, catalyzed by EZH2
in the PRC2 complex, is opposed by MLL complexes,
which mediate methylation of H3K4me2/3, a mark asso-
ciated with loci that are actively transcribed or primed for
activation. WDR5 is an integral part of all MLL com-
plexes, but also interacts with several other protein
complexes [60]. WDR5 has been found to interact with
more than 200 lncRNAs in mouse embryonic stem cells
(mESCs) [61]. These interactions are important for WDR5
binding to chromatin since a point mutant that cannot bind
RNA also fails to stably associate with chromatin. More
specifically, two lncRNAs, HOTTIP and NeST have been
described to recruit WDR5 to their neighboring genes and
thus enhance their transcription [62, 63].
LncRNAs modulate DNA methylation
Whereas many lncRNAs associating with Polycomb com-
plexes act by promoting PRC occupancy at genomic target
sites, lncRNAs described in the context of DNA methyla-
tion have mostly been found to oppose this epigenetic mark.
Frequently, transcription of noncoding RNAs, which
interact with DNMTs, keeps a locus free of DNA methy-
lation [54, 64–66] (Fig. 2a). Initially, it was observed that
knockdown of extracoding CEBPA (ecCEBPA), a transcript
starting upstream of the CEBPA gene, leads to down-reg-
ulation of CEBPA and increased DNA methylation of the
locus. A subsequent global analysis of all lncRNAs bound
to DNMT1 [64] revealed that loci whose RNA products
interact with DNMT1 show lower levels of DNA methy-
lation than other loci. A similar observation was made in
oocytes and two-cell stage embryos [66], in which the
down-regulation of several divergently transcribed pro-
moter-associated ncRNA (pancRNA) led to lower
expression of the adjacent protein-coding gene and higher
DNA methylation. In the case of one particular gene, IL17b,
the pancRNA knockdown resulted in cell death of the
developing blastocyst. Supplementing the embryos with
IL17b protein rescued the phenotype.
In the case of Tcf21 antisense RNA reducing DNA
methylation (TARID), keeping the protein-coding gene
(Tcf21) on the opposite DNA strand free of DNA methyla-
tion required GADD45A and the TET proteins [65] pointing
towards a mechanism involving active DNA demethylation.
LncRNAs regulate chromatin remodeling
In addition to interaction with enzymatic complexes, which
covalently modify chromatin, lncRNAs have also been
shown to control chromatin remodeling complexes that can
alter the nucleosome spacing in an energy dependent
manner. In human prostate cancer, gene expression anal-
yses showed that SWI/SNF and the lncRNA SChLAP1
have opposing roles. SChlAP1 interacts with the SNF5
subunit of the chromatin remodeling complex SWI/SNF,
Mechanisms of long noncoding RNA function in development and disease 2497
123
and globally inhibits binding of SWI/SNF to chromatin,
subsequently leading to genome-wide de-repression of
gene activity [67]. Similarly, the lncRNA Myheart (Mhrt),
a lncRNA transcribed divergently to Myh6 and overlapping
with Myh7 in antisense direction, binds to BRG1, the
ATPase subunit of the SWI/SNF complex, and excludes it
from the Myh6/7 locus, thus preventing chromatin remod-
eling [68]. BRG1, in turn, down-regulates Mhrt. Cardiac
stress leads to upregulation of BRG1 to a level allowing it to
overcome the repulsion of the SWI/SNF complex from
chromatin by Mhrt and to bind to the Myh6 locus.
The Evf2 lncRNA, transcribed from the genomic region
between Dlx5 and Dlx6, promotes SWI/SNF binding to the
enhancers of these genes. However, Evf2 inhibits the
remodeling activity of SWI/SNF and thus interferes with
upregulation of Dlx5/Dlx6. Accordingly, in Evf2 mutant
mice, Dlx6 and, to a lesser extent, Dlx5 are upregulated
[69, 70]. In a more recent study, it was observed that the
binding of Evf2 to BRG1 can be out-competed by other
RNAs of similar length and results in reduced remodeling
activity, suggesting that the binding of lncRNAs to the
SWI/SNF complex is promiscuous. Xist, on the other hand,
binds to components of the SWI/SNF complex, but
excludes the complex from the Xi, rather than recruiting it
[71]. The SWI/SNF complex can also be recruited by
lncRNAs and mediate gene activation, as has been found in
hepatocellular carcinoma cancer stem cells. A lncRNA,
lncTCF7 or WNT signaling pathway activating non-coding
RNA (WSPAR), transcribed 200 kb upstream of TCF7, can
recruit SWI/SNF to the TCF7 promoter and thus activate
TCF7 expression and WNT signaling [72].
Is the observed binding of numerous lncRNAs
to chromatin modifiers specific or promiscuous?
The specificity of lncRNA interactions with chromatin-
modifying complexes has been questioned. For instance, a
large number of lncRNAs have been shown to co-purify
with PRC2, possibly suggesting non-specific binding [50,
52, 73]. Similarly, 15 % of all lncRNAs present in a par-
ticular cellular context were shown to be bound by DNMT1
[64, 74]. Likewise, WDR5 binds to more than a thousand
RNAs in mESCs, of which 20 % are lncRNAs [61]. This
issue of promiscuity was assessed exemplarily for PRC2 in
a systematic biochemical study [75], where the authors
demonstrate that PRC2 binds RNA in a promiscuous
manner, but has remarkably higher affinity for specific
lncRNAs than for e.g. bacterial mRNA. Furthermore, they
provide evidence that the binding strength correlates with
the length of the RNA. Though these studies were per-
formed in vitro at non-physiological conditions, they
suggest that the chromatin-modifying complexes can suf-
ficiently differentiate between specific and non-specific
interactors. Moreover, since most lncRNA transcripts are
expressed at few copies per cell, it is likely that the number
of PCR2 molecules per cell is in excess to the number of
lncRNA transcripts, which contain a high affinity site for
PRC2. Overall, it is not unexpected that a chromatin-mod-
ifying complex acting at numerous genomic loci binds
many different individual lncRNAs, which stabilize it or
recruit it to distinct genomic loci.
Interactions of lncRNAs with transcription factors
Besides chromatin modifiers, transcription factors have
also been found to interact with lncRNAs. The lncRNA
definitive endoderm-associated lncRNA1 (DEANR1) (also
known as ALIEN), for instance, is transcribed downstream
of FOXA2 and is highly induced during differentiation of
ESCs towards definitive endoderm [76, 77]. Knockdown of
DEANR1 inhibits endodermal differentiation due to the
reduction of FOXA2 expression. This interpretation is
strongly supported by the fact that endoderm differentia-
tion is rescued in DEANR1 knockdown cells upon forced
FOXA2 expression. Mechanistically, DEANR1 was pro-
posed to interact with SMAD2/3 and to recruit it to the
FOXA2 promoter.
The lncRNA rhabdomyosarcoma associated transcript
(RMST) is required for neuronal differentiation bymediating
binding of the transcription factor SOX2 to approximately
half of its binding sites [78]. Certain lncRNAs have been
linked in different ways to transcription factors of the NF-jB
pathway. Lethe (after the ‘river of forgetfulness’ in Greek
mythology) interacts with RelA and prevents it from binding
to DNA [79]. p50-associated cyclooxygenase-2 (COX-2)
extragenic RNA (PACER), on the other hand, sequesters p50,
which forms homodimers and is repressive at high concen-
tration, thereby lowering its concentration and allowing it to
form activating heterodimers with p65 [80]. Another
lncRNA, lnc dendritic cells (lnc-DC) binds to the tran-
scription factor STAT3 in the cytoplasm and prevents its
dephosphorylation by SHP1, thereby activating STAT3 and
thus dendritic cell differentiation [81].
An elaborate mechanism linking transcription factor
binding and chromatin modifications has been found for
breast cancer anti-estrogen resistance 4 (BCAR4). This
lncRNA binds to the SMAD nuclear interacting protein 1
(SNIP1) and a phosphatase (PNUTS) involved in RNA
polymerase II regulation. In response to cytokine stimula-
tion, BCAR4 lifts the inhibitory effect of SNIP1 on p300, a
histone acetyl transferase and transcriptional activator.
Acetylated histones are necessary for BCAR4 mediated
recruitment of PNUTS, which in turn leads to active
polymerase II at GLI2 controlled genes [82].
Also CTCF, a protein with the dual function of a tran-
scriptional regulator and a boundary factor, has been shown
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to interact with numerous noncoding RNAs [83]. An
example is the interplay between CTCF and the lncRNAs
Jpx, Tsix and Xite, which is important for X-chromosome
inactivation [83, 84]. Prior to inactivation, Tsix and Xite
recruit CTCF in cis to the X-inactivation center promoting
homologous X-chromosome pairing at the Xic [83]. During
X-chromosome inactivation, Jpx evicts CTCF in trans
from the Xist locus and thereby prevents promoter block-
age by CTCF [83]. These examples illustrate the dynamic
interaction between lncRNAs and transcription factors in
regulating chromatin-mediated cellular functions.
Regulation of genome organization by looping
of enhancers
Previously, transcripts found at enhancers had been inter-
preted as byproducts of transcription from promoters
contacted by enhancers. Now, it is well established that
RNA transcripts produced at active enhancers are func-
tionally important [85–87]. An example of enhancer-linked
transcripts, already identified two decades ago, has been
described for the locus control region (LCR) of the b-globin
cluster [88, 89]. To date, numerous studies have assigned
functions to enhancer-associated RNAs [90] (Fig. 2b). There
are different classes of RNAs observed at enhancers. The
classical enhancer RNAs (eRNAs) are derived from bidi-
rectional transcription, are unspliced and rather short
transcripts [85, 91]. Additionally, there are also unidirec-
tional, often spliced and processed transcripts, which are
indistinguishable from canonical lncRNAs, but happen to be
transcribed from an enhancer [23, 92]. These transcripts
often function in cis. Finally, there are lncRNAs with
enhancer-like functions (also called ncRNA-a) [93]. Whe-
ther this classification reflects different functional classes of
RNAs remains to be investigated.
In general, eRNAs are co-regulated with their neigh-
boring gene(s) [91] and presumed to be important for gene
expression, possibly by supporting cohesin binding [94].
However, experimental support for the latter is rather mild.
While eRNAs in some studies were shown to stabilize
chromosome loops [94, 95], they appeared to be dispens-
able for promoter-enhancer contact in others, raising
doubts about the role of eRNAs in chromosome looping
[96, 97].
LncRNAs transcribed from enhancer regions can also
have inhibitory effects on their target gene. The promoter
deletion of the lncRNA Haunt (also known as linc-Hoxa1),
for instance, has been shown to lead to upregulation of
several genes of the neighboring HoxA gene cluster.
However, larger deletions in the Haunt locus impair HoxA
expression [98], demonstrating that the genomic locus can
have opposing functions to the RNA product encoded by it.
The repressive effect of Haunt was furthermore observed at
the single cell level confirming that the expression of
HoxA1 and Haunt are anti-correlated [99].
A similar mechanism was found for Playrr
(D030025E07Rik), a lncRNA encoded upstream of the
homeodomain transcription factor Pitx2 [100]. Pitx2
expression is constrained to the left side of the gut dorsal
mesentery, whereas expression of Playrr is detected on the
right, but spreads to both sides in Pitx2 deletion mutants.
A CRISPR/Cas9 generated mutation resulting in Playrr
RNA decay caused upregulation of Pitx2 expression [100].
Both experiments reveal a mutual inhibitory interaction
between Pitx2 and Playrr. An enhancer involved in Pitx2
regulation in the gut overlaps the TSS of Playrr. In the
cells on the left-hand side, where Pitx2 is expressed, the
Pitx2 locus was found to be in closer proximity to the
Playrr locus than in cells on the right side and to cause
down-regulation of Playrr by an unknown mechanism. In
cells on the right, on the other hand, Playrr RNA is thought
to cause a separation of the Pitx2 locus from the enhancer
at the Playrr locus suggesting that Playrr expression
interferes with the looping of the Pitx2 promoter to its
enhancer at the Playrr locus and thus with Pitx2 gene
activation (Fig. 2c).
Furthermore, the lncRNAs PRNCR1 and PCGEM1
promote enhancer-promoter looping in prostate cancer
cells [101]. Other lncRNAs have been suggested to assist
chromosome conformation more globally. A particular
situation can be observed at the inactive X-chromosome
(Xi). The 3D-structure of Xi is dependent on Xist, sup-
posedly because Xist excludes cohesin binding from Xi
[71]. Deletion of Xist led to loss of the compact chromo-
some structure of the Xi and reorganization into
chromosome domains as they are found on the active
X-chromosome. Recently, another lncRNA, functional
intergenic repeating RNA element (Firre), which escapes
X-chromosome inactivation was suggested to stabilize the
perinucleolar location of the Xi [102]. Additionally, Firre
was proposed to mediate focal trans-chromosomal contacts
[103]. This finding was questioned by a different study,
which reported a dispersed nuclear distribution of Firre
and a role in the control of factors involved in RNA pro-
cessing [104]. These examples show that lncRNAs can
play important roles in controlling local intra- and inter-
chromosomal genomic structure and interactions.
Regulation at the posttranscriptional level
LncRNAs primarily found in the cytosol are thought to be
involved in gene regulation on the posttranscriptional
level (Fig. 2e–h). Accordingly, several lncRNAs have been
shown to influence splicing patterns of either specific genes
or globally by interacting with splicing factors. The
lncRNA Pnky (divergent to Pou3f1) binds to the splicing
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factor PTBP1 and thereby regulates the splicing patterns of
a subset of genes involved in neurogenesis [105]. Whether
TUNA (megamind), which interacts with PTBP1 as well,
functions via the same mechanism remains to be investi-
gated [33, 106]. In addition, myocardial infarction
associated transcript (MIAT) has been found to influence
splicing in different systems. In embryonic neurogenesis,
MIAT is involved in controlling the splicing pattern of
Wnt7b [107]. In iPS cells and mouse primary neurons,
MIAT binds to splicing factors, and in post-mortem brains
of schizophrenia patients, it was found to be down-regu-
lated, suggesting that it might contribute to this
pathological phenotype [108].MALAT1, a highly expressed
lncRNA enriched in nuclear speckles, has been suggested
to be a general component of the splicing machinery [109].
However, this view has been challenged since the MALAT1
knockout did not show disintegration of splicing speckles
[110]. A very specific role in the cytoplasm was found for
the lncRNA non-coding RNA activated by DNA damage
(NORAD) [111]. NORAD sequesters PUMILIO proteins
and thereby promotes genomic stability (Fig. 2f). Ablation
of NORAD leads to hyperactivity of PUMILIO causing
chromosome instability and aneuploidy due to repression
of PUMILIO target mRNAs that function in DNA repli-
cation, mitosis and DNA damage repair.
The most recently described class of lncRNAs that came
into focus are the circRNAs. Due to their circular structure,
they are resistant to degradation by exonucleases and are
therefore thought to be highly stable within a cell. The
brain specific circRNA CDR1as was shown to act as a
sponge for the miRNA let-7 [26, 27] (Fig. 2f). Accord-
ingly, overexpression of CDR1as in zebrafish caused
impaired midbrain development, similarly to the effect of a
let-7 inhibitor. It was also shown that small polypeptides
can be derived from some circRNAs, extending the func-
tional repertoire of these stable RNA molecules [112].
Most likely, circRNAs do not only interact with other
transcripts, but also with proteins and thus may function in
a wide range of different processes.
Functions of lncRNAs in development
and differentiation
In the following section, we will focus on the physiological
effects of lncRNAs in the organism, during embryonic
development and in in vitro differentiation systems. There
are still few known examples of lncRNAs shown to play
important roles in vivo, and thus we will revisit some of the
lncRNAs already mentioned above.
Maternal transcripts present in oocytes and zygotes
contribute to early differentiation processes. In a single-cell
sequencing study examining oocytes, zygotes and cells
from the first cell divisions of the early mouse embryo,
lncRNA transcripts were found at all stages examined
[113]. One subclass of lncRNAs, the pancRNAs, was
compared between murine two-cell embryos and oocytes
[66]. A subset of pancRNAs found to be expressed in two-
cell embryos but not in oocytes was found to be important
for counteracting DNA methylation at the adjacent pro-
moters thereby ensuring expression of the neighboring
gene.
The mechanisms first found to be linked to lncRNAs
were imprinting and X-chromosome inactivation. Accord-
ingly, the first lncRNA that was genetically targeted and
deleted was H19, an imprinted gene that was already sus-
pected to be a lncRNA 25 years ago [114]. H19 is
exclusively expressed from the maternal allele and is
inhibitory for the adjacent gene, Insulin-like growth factor
2 (Igf2) [114–116]. An H19 deletion on the maternally
inherited chromosome led to an increase in Igf2 expression
and thus to increased bodyweight. This phenotype could be
rescued by deletion of one Igf2 allele. H19 knockout mice
are viable and fertile [116], but have reduced muscle
regeneration capacities due to loss of two miRNAs enco-
ded within the H19 transcript [117]. The imprinted Igf2r
gene is silenced by the lncRNA Airn, which is transcribed
from the opposite strand, overlapping the 5-prime region of
Igf2r. Here, silencing is not achieved by the lncRNA
transcripts as such, but by transcription through the Igf2r
promoter, which interferes with RNA PolII recruitment
[118]. Several further lncRNAs with a well-established role
in imprinting have been reported. For details we would like
to refer to a recent review [119].
Insight into the developmental function of Xist was
obtained two decades ago when Xist knockout mice were
generated and analyzed [120, 121]. Male mice lacking Xist
are unaffected, whereas females die during the first half of
gestation. Interestingly, knockout females with a single
X-chromosome (XO) lacking Xist are healthy, strongly
suggesting that it is not the lack of Xist, but the failure to
adjust the X-chromosome gene dosage that causes
embryonic lethality.
In a more recent example, the deletion of another
imprinted lncRNA gene in the mouse, Gtl2 (Meg3, ma-
ternally expressed 3), showed clear cis-acting effects on
neighboring genes resulting in perinatal lethality [122].
Many other mouse models in which lncRNAs have been
removed by deletion of genomic fragments did not show
overt phenotypes, but after detailed analyses, some specific
defects have been observed [110, 123–126]. For instance,
deletion of NEAT1 resulted in viable and fertile mice,
however, knockout females showed about 50 % reduced
fertility due to reduced progesterone production and corpus
luteum formation [127]. Ovary transplantation or proges-
terone administration rescued offspring rates, confirming
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the cause of the phenotype, though the molecular mecha-
nism remains to be determined.
Fendrr is one of few rare examples of lncRNAs
demonstrated to play an essential role in organ develop-
ment and embryo survival. Fendrr, which is divergently
transcribed from the Foxf1 promoter, was analyzed by two
different strategies [47, 123]. In one study, the insertion of
a transcriptional stop cassette replacing the first exon of
Fendrr leaving most of the genomic context undisturbed
resulted in impaired heart function, omphalocele (defects
in body wall development), and embryonic death [47].
Fendrr interacts with chromatin-modifying complexes and
with DNA, possibly through triplex formation, and thereby
changes the chromatin landscape of specific target pro-
moters in trans, in particular those of mesodermal
transcription factors [46]. A BAC-transgene expressing a
single dose of Fendrr rescued the developmental defects
caused by the loss of Fendrr, strongly suggesting that the
observed phenotype is caused by lack of Fendrr RNA, and
not by disruption of genomic sites or promoter elements of
the adjacent Foxf1 gene. This conclusion was supported by
a different knockout strategy, in which the first exon was
left intact and which resulted in perinatal death [123]. In
the early embryo, Fendrr is only transiently expressed in
nascent lateral mesoderm [47]. However, later during
development it is expressed in the lungs, a derivate of
endoderm and lateral mesoderm, where it again might play
an essential role [123, 128].
More lncRNAs involved in mesoderm and endoderm
development have been reported. For instance DEANR1
(also known as ALIEN) is expressed downstream of the
endoderm master regulator FOXA2 [76, 77]. DEANR1
depletion results in reduced expression of FOXA2 and
accordingly to reduced differentiation of hESCs towards
definitive endoderm. Interestingly, this defect can be res-
cued by restoring normal levels of FOXA2 expression,
suggesting that DEANR1 functions mainly in cis. Another
study described the same lncRNA, here called ALIEN, in
cardiovascular progenitor cells in mouse and zebrafish.
Depletion of ALIEN interfered with cardiac development,
although the functional mechanism remains to be investi-
gated further. DEANR1 was described to be localized in the
nucleus, whereas ALIEN was seen in the perinuclear space
and in the cytoplasm, even though both were analyzed in
differentiating human stem cells. The discrepancy between
the two studies might be a consequence of modifications in
the differentiation method [76, 77].
Also, the transcription factor Pitx2, which is essential
for the development of many different organs, especially
during the establishment of left–right asymmetry, is regu-
lated by a lncRNA in the embryonic gut [100]. In this case,
the lncRNA Playrr is transcribed from a distant known
enhancer region. The expression patterns of Pitx2 and
Playrr are negatively correlated due to interference of
Playrr with Pitx2 activation (for details see above).
LncRNAs expressed during neuronal and brain devel-
opment have attracted particular attention. As described
earlier, many lncRNAs are highly specifically expressed in
distinct cell types, as illustratively shown in a targeted
LacZ reporter screen [37] and in expression screens [36,
107, 129, 130]. A number of lncRNAs located close to the
PouIII genes Pou3f3 and Pou3f2 (Brn1 and Brn2) encoding
important neuronal transcription factors, were also found to
play roles in neuronal development [37, 105, 123, 131].
The lncRNA Dali (or Dalir) (DNMT1-Associated Long
Intergenic RNA) is transcribed 50 kb downstream of
Pou3f3. The depletion of Dali leads to a reduction of
Pou3f3 expression and to impaired neuronal differentiation
[131]. Gene expression analysis upon knockdown and
genome-wide localization (CHART) revealed POU3F3
dependent and independent targets of Dali. Furthermore,
Dali physically interacts not only with various chromatin
modifiers, but also with POU3F3 itself suggesting a mul-
tilayered association between Dali and POU3F3. The
replacement of Pantr1 (POU domain, class 3, transcription
factor 3 adjacent noncoding transcript), which is diver-
gently transcribed to Pou3f3, by insertion of the lacZ gene
did not influence Pou3f3 transcription itself, but modulated
other Pou3f transcription factors in trans [37]. Pantr2 (or
Linc-Brn1b), expressed convergent with Pou3f3, did not
have this effect on Pou3f factors, and upon deletion led to
fewer intermediate progenitors in the developing cortex.
Thus, each of these three different lncRNAs, which are all
transcribed near the Pou3f3 locus, affect neuronal devel-
opment yet through distinct mechanisms.
Furthermore, another lncRNA located in a region
important for neural development is Evf2 in the Dlx5/6
locus [69]. Evf2 was targeted by inserting a polyadenyla-
tion signal close to the promoter without deleting genomic
DNA. Evf2-/- embryos have less GABAergic neurons than
wild type controls. This mutant effect could be rescued by
in utero electroporation of Evf2 RNA, confirming that the
phenotype is indeed dependent on this lncRNA.
RMST, also termed non-coding rhabdomyosarcoma
(NCRMS) in humans, is a noncoding transcript expressed in
rhabdomyosarcomas [132] and in developing dopaminergic
neurons during murine development [133]. RMST is
induced during neuronal differentiation of hESCs, and its
depletion interferes with neuronal differentiation via its
binding partner SOX2 (see above) [78, 107, 129]. Inter-
estingly, RMST was found associated with obesity in a
GWAS study, possibly pointing to a role of RMST in a
neuronal regulatory network influencing energy balance
[134].
Two more lncRNAs involved in nervous system devel-
opment are the retinal noncoding RNA2 and 4 (RNCR2 and
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RNCR4). They were first found to be expressed in the
developing retina and later also assigned a functional role
in this process [135]. RNCR4 is part of a network including
the RNA helicase DDX3X and the miR-183/96/182 that is
essential for retinal architecture [136]. RNCR2, also known
as MIAT or Gomafu, interferes with retinal cell differenti-
ation when overexpressed or depleted [135, 137].
Furthermore MIAT is expressed earlier in the developing
brain, where it localizes to the nuclear matrix [138]. Puri-
fying distinct subpopulations of the developing brain at
E14.5 revealed that MIAT is highly abundant in differen-
tiating progenitors, where it is involved in corticogenesis
by regulating the splicing pattern of Wnt7b [107] (Fig. 2g).
Another ectodermal derivative, the developing epider-
mis, has also been shown to be regulated by lncRNAs.
During epidermal differentiation and maintenance, the
nuclear lncRNA ANCR (anti-differentiation ncRNA) is
essential for maintaining the proliferating progenitor pool
by repressing differentiation factors, amongst them the
transcription factors MAF and MAFB, probably in a PRC2
linked manner [139–141]. Depletion of ANCR leads to
differentiation and loss of progenitor cells. Its differentia-
tion promoting counterpart is a cytosolic lncRNA, terminal
differentiation induced ncNRA (TINCR) that interacts with
STAU1 and as a protein-RNA complex stabilizes mRNAs
of pro-differentiation genes including MAF and MAFB
[141, 142] (Fig. 2h). Ectopic expression of MAF:MAFB in
TINCR depleted cells restored the expression of the dif-
ferentiation gene signature showing that TINCR is crucial
for ensuring appropriate protein levels in particular of
MAF and MAFB.
Functions of lncRNAs in pathological settings
LncRNAs as a ‘‘new’’ class of molecules have also
attracted attention in pathological settings. Here, we will
highlight two very prominent areas, cancer and cardio-
vascular disease.
Cancer
Approximately one third of publications currently listed in
PubMed linked with the keyword ‘‘lncRNA’’ also contain
the keyword ‘‘cancer’’. Even before the era of next gener-
ation sequencing, a few studies found lncRNAs to be
dysregulated in tumors [35, 143, 144]. To date, numerous
primary tumor samples, metastatic biopsies, the adjacent
normal tissue and cancer cell lines have been profiled for
their RNA expression and the results recapitulate the high
degree of specificity found for noncoding RNAs in normal
tissue compared to protein-coding genes [25, 67, 145–147].
Clustering of lncRNA expression patterns identifies
subclasses of tumor types with high significance, opening
the possibility to define tumor subtypes with a high chance
to respond to targeted therapy. A study that considered
samples from more than 5000 tumors from the cancer
genome atlas (TCGA) project, demonstrated that, while
approximately the same number of protein coding and
lncRNA genes were dysregulated, 60 % of lncRNAs
showed specificity for only one tumor type [146].
In addition, somatic copy number alterations (SCNA)
found in cancer tissue often include lncRNA loci [57, 146,
147]. For example, the lncRNA FAL1, a lncRNA that was
found amplified in a number of different tumor types, was
shown to be important for the tumorigenic effects of different
cell lines via a BMI1-mediated mechanism (see above), and
its expression level and copy number significantly correlated
with patient survival [57]. Furthermore, several lncRNAs
have been shown to be prognostic for overall or disease-free
survival of patients [67, 82, 148–150], information that is
integrated into therapeutic decisions. Depletion of selected
lncRNAs led to reduced malignancy, assayed as tumor size
or metastatic potential in xenograft experiments [67, 72, 82,
101, 148, 149, 151–154], although these experiments were
not able to distinguish between effects on tumor formation
versus tumor progression. Further refinement was achieved
when RNA knockdown was induced after tumor formation,
mimicking therapeutic conditions. Reduced tumor growth
was, for instance, observed upon FAL1 depletion [57]. In a
different study, the inhibition of MALAT1 after tumor
induction reduced metastasis formation in a xenograft lung
cancer model and in a metastasizing breast cancer model
[149, 155]. MALAT1 knockout mice do not show overt
phenotypes [110, 156, 157] suggesting that down-regulation
of MALAT1 in humans might also not be harmful for normal
human cells, which makes it an attractive target for systemic
application in patients.
A special case is the noncoding pseudo gene BRAFP1,
which has been shown to be either mutated or aberrantly
expressed in cancers, like its coding homologue BRAF. A
mouse model revealed that induced overexpression of
Braf-rs1 (the murine homologue of BRAFP1) leads to
DLBCL (diffuse large B cell lymphomas)-like tumors.
However, when the transgene was first induced to form
tumors and then shut down again, the tumors regressed
demonstrating the functional significance of the pseudo
gene [158]. Braf-rs1 was shown to cause upregulation of
Braf by acting as a ceRNA (competing endogenous RNA)
and by ‘‘sponging’’ miRNAs that would otherwise target
Braf transcripts.
One mechanism that cells can employ to prevent tumor
formation is oncogene-induced senescence (OIS) [159].
The INK4B-ARF-INK4A locus, which plays a major role in
OIS, is silenced in proliferating cells by Polycomb group
proteins. This mechanism is dependent on the lncRNA
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ANRIL, which is transcribed from within the locus and acts
in cis [58, 59, 160]. Furthermore, the MIR31HG gene
located 400 kb upstream of the INK4B-ARF-INK4A locus,
also encodes a lncRNA involved in the regulation of
INK4A [161]. A third lncRNA functioning in OIS, UCA1,
stabilizes mRNAs of protein-coding genes involved in the
senescence pathway, probably by sequestering hnRNPKA1
[162]. Also, the tumor suppressor p53 and its associated
signaling pathways include lncRNAs. p53 binds and reg-
ulates numerous lncRNAs, such as the linc-p21, which in
turn regulates gene expression in concert with p53 and p21
[163–166].
Cardiovascular diseases
LncRNAs have also been linked to cardiovascular diseases
(CVD), which are a major cause of death in western
societies, and have been studied both in patient data, as
well as in mouse models. It was observed that several
genomic regions significantly associated with myocardial
infarction encode lncRNAs, for example MIAT and ANRIL
[167, 168]. Deletion of a 70 kb region including a large
proportion of the ANRIL locus led to increased mortality
in mice, particularly in combination with a high fat diet
[169].
In other studies, massive parallel RNA sequencing
revealed numerous lncRNAs displaying altered expression
following surgically-induced myocardial infarction in mice
[170, 171]. In cellular differentiation models, the depletion
of selected lncRNAs impaired cardiomyocyte formation
making them promising candidates for in vivo assessment
of their functions [172]. Analysis of the noncoding tran-
scripts originating from the myosin heavy chain 7 (Myh7)
locus, an important structural protein required for heart
contractions, revealed that one, the lncRNA Mhrt, was
down-regulated after induced myocardial infarction. Ecto-
pic expression of Mhrt in mice, which had been subjected
to this operation reduced the severity of symptoms
observed in control mice during recovery [68]. When
lncRNAs in plasma from myocardial infarction patients
were profiled, a mitochondrial lncRNA named long inter-
genic noncoding RNA predicting cardiac remodeling
(LIPCAR) was found to significantly correlate with mor-
tality caused by CVD and could thus be considered as a
biomarker [173]. Whether this lncRNA also plays a cau-
sative role in infarction or heart failure remains to be
investigated.
LncRNAs have been widely suggested as biomarkers
and therapeutic targets in certain pathological settings. One
reason for this is the extremely specific expression of many
lncRNAs, opening the potential of targeting cellular sub-
groups rather than affecting patients systemically as in
conventional treatments. Even if a lncRNA itself is not the
disease driver, it can serve as drug target in cases where it
acts as co-factor for a driver gene, which is more broadly
expressed. Also, since lncRNAs often play quantitative
roles rather than acting as switches in genetic programs,
side effects of therapeutic treatments might be easier to
control.
Concluding remarks
In recent years, the analysis of lncRNAs has highlighted
the large diversity of cellular functions involving RNA
molecules and has greatly expanded the catalog of func-
tions previously attributed to noncoding RNAs. By now,
we can conclude that noncoding RNAs play roles at all
levels of gene control, including epigenetic mechanisms
and nuclear organization, as well as in RNA processing,
stability and translation. The recent discoveries of
lncRNA functions provide good reasons for the notion
that further investigation of lncRNAs bears high chances
for the discovery of novel gene regulatory mechanisms in
the future.
So far, only few lncRNAs playing an essential role in
embryonic development, organogenesis or tissue homeosta-
sis have been reported. Studies based on in vitro
differentiation systems can provide important insights into
the molecular modes of lncRNA function in local gene
control or in regulatory networks. However, with regard to
the roles of lncRNAs, for example in lineage decisions and
cellular differentiation many findings are hampered by the
lack of definitive proof in vivo. In particular, data derived
from in vitro differentiated stem cells, whose genomic
integrity and quality is hard to control, have to be interpreted
cautiously. Also, the type of genetic change introduced into a
lncRNA gene/locus for functional analysis (transcription
stop, knockin, deletion etc.) needs to be considered carefully
in order to draw the right conclusions [174–176]. Since
lncRNAs do not only act as transcripts in cis or trans, but can
also be side products of transcription affecting the expression
of overlapping genes or accommodate regulatory DNA ele-
ments in their genomic loci, the analysis of their exact mode
of action and functional roles in development and disease
processes is more complex and difficult than that of protein-
coding genes. It is now up to the responsibility of journal
editors and reviewers to enforce the high standards of
investigation this new and exciting field of research deserves.
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